The pooled results (OR = 0.65, 95% CI 0.35 to 1.21; P = 0.17) showed that the odds of positive PD-L1 expression in PCa patients with N0 were 35% lower than those with N1. The gene discussed is CD274; the disease is posterior cortical atrophy.